OBSERVATIONS IN DIAGNOSIS AND TREATMENT OF ORAL CANCER OVER THE PAST 45 YEARS Lessons remain in identifying malignant disorders and prevention across health settings
With
Professor Peter Thomson,
Head of Dentistry and Professor of Oral and Maxillofacial Sciences
James Cook University, Cairns
SEGMENT
Filmed in the Gold Coast | May 2026
Peter Thomson is Academic Head of Dentistry and Professor of Oral & Maxillofacial Sciences in the College of Medicine & Dentistry at James Cook University, Australia. A UK and Australian specialist in Oral & Maxillofacial Surgery and Oral Medicine, he qualified BDS from Manchester University and MBBS from Newcastle upon Tyne, gaining Fellowships in Dental Surgery from the Royal College of Surgeons of England, Ireland and Glasgow and a Fellowship in Surgery from Edinburgh, specializing in Head & Neck Oncology.
He completed MSc and PhD degrees in epithelial biology and cancer research at Manchester University, where he was Lecturer, before returning to Newcastle in 1996 as Professor of Oral & Maxillofacial Surgery. In 2009, he was appointed Hunterian Professor at the Royal College of Surgeons of England and in 2011 King James IV Professor at the Royal College of Surgeons in Edinburgh. In 2014, he gained a Manchester Higher Doctorate (DDSc) for oral oncology research, and in 2016 an MD from the University of Bath for his thesis on interventional management of potentially malignant disorders.
Developing an extensive international profile, Peter was appointed Visiting Professor at the National University of Singapore in 2014 before joining the University of Queensland’s School of Dentistry as Professor of Maxillofacial Surgery & Academic Clinical Director in 2016. He was recruited to The University of Hong Kong in October 2017 to become Associate Dean at the Faculty of Dentistry and Director of the Prince Philip Dental Hospital. He has also held Academic Head and Dean of Dentistry positions at the University of Central Lancashire, UK and Griffith University in Australia. He was invited to join James Cook University as Head of Dentistry in 2021.
Author of more than 350 research papers and 2 oral cancer textbooks, Peter is an internationally recognised authority in oncology, population health and dental education. His research emphasis encompasses oral carcinogenesis, epithelial cell biology, and the early diagnosis and interventional management of cancer.
Source: James Cook University website
Media access credit: Oral Health Association of Australia (OHAA)
-
Global collaboration in pulmonary fibrosis research
Pulmonary fibrosis is a lung disease that occurs when lung tissue becomes damaged and scarred. The debilitating and fatal disease ended the life of an Australian man 8 years ago.
His son led philanthropic efforts to establish the connection between 2 Australian organisations; Lung Foundation Australia and Centre for Research Excellence in Pulmonary Fibrosis and the US based, Three Lakes Foundation. The three organisations recently announced a collaboration to create a global network for PF research.
-
Interventional radiologists offer alternative to hysterectomy
In Australia in the last five years, an estimated 6066 women per year have undergone hysterectomies to treat fibroid-related diseases, while just 145 women each year have undergone a uterine artery embolisation, or UAE.
The procedure can effectively treat the majority of bleeding uterine fibroids. Each year, thousands of Australian women undergo invasive and life-altering hysterectomies to treat debilitating pain and blood loss caused by uterine fibroids. But there’s another option: a minimally invasive, pin-hole procedure that treats the symptoms, yet leaves the uterus intact.
-
Medicinal cannabis in Australia Update
According to the Australian Journal of General Practice, published by the Royal Australian College of General Practitioners, more than 130,000 medicinal cannabis approvals have been issued in Australia to date, mostly by general practitioners, with approximately 65% of these to treat chronic non-cancer pain. Despite robust supportive data from animal models, current clinical trial evidence for THC and CBD efficacy in chronic pain is incomplete. In their prescribing decisions, doctors must balance patient demand and curiosity with caution regarding potential risks and limited efficacy (Source: https://www1.racgp.org.au/ajgp/2021/october/medicinal-cannabis)
Australian Health Journal met with 3 speakers at the recent @arcsaustralia ARCS22 Conference providing an update on medicinal cannabis. The discussion with the speakers now centres on affordability and access.
